Search

everythinglearnresearchcommunity

for

Search:↓

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Nerves and chemicals in the body can affect hair growth and loss.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

FFA's causes may include environmental triggers and genetic factors.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Alefacept showed some effectiveness for alopecia areata but needs more research.

COVID-19 infection may trigger alopecia areata in some patients.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Immune cells affect hair growth and could lead to new hair loss treatments.

IGF-1 affects hair loss and could be a potential treatment.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.